Abstract: This invention relates to novel indane acetic acid derivatives which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases. The invention also relates to intermediates useful in preparation of indane acetic derivatives and to methods of preparation.

Abstract: A process for amino acid derivatives shown by the below general formula (I): (wherein R1 means a hydrogen atom or a straight chain or branched chain alkyl group with 1-5 carbon atoms.) having an object to provide a process of the amino acid derivatives of the formula (I) and their synthetic intermediate, t-butoxycarbonylamino-ethylamine, whereby it requires no tedious procedure and is also good in yield, and its application to a mass production is easy, and to provide novel amino acid derivatives of the formula (IV), their synthetic intermediates, and a process thereof, characterized in that it comprises a step to obtain the amino acid derivatives shown by the general formula (I) by hydrolysis of compounds shown by the below formula (II): (wherein R1 has the same meaning as described above, and R2 means a straight chain or branched chain alkyl group with 1-4 carbon atoms.

Abstract: The present invention is to provide a method for producing the desired optically active ?-amino acid derivatives of high optical purities in high yields, without requiring a step of deprotection. More particularly, the present invention relates to a method for producing an optically active ?-amino acid derivative or a salt thereof represented by the formula (2): which comprises reacting an ?,?-unsaturated carboxylic acid derivative or a salt thereof represented by the formula (1): with an amines or a salt thereof in the presence of a chiral catalyst and in the presence or absence of an acid.

Abstract: Novel ligand antagonists of the RAR receptors have the following structural formula (I): in which A is a CH2, CHOH, C?O or C?N—OH radical or a sulfur or selenium atom; B is a radical selected from among those of formulae (a) to (f): and Ar is a radical selected from among those of formulae (g) to (i):

Abstract: The invention relates to the fields of fatty substance chemistry, specifically of the ceramide-type compound synthesis. The invention resides substantially in the synthesis of ceramide-type compounds. Specifically, the aim of the invention is a new enzymatic synthesis method, comprising at least one amidification step and one esterification step, achieved through lipases, among fatty acids and/or esters thereof and amino alcohols. The resulting ceramide-type compounds can be used as cosmetic and/or pharmaceutical compositions, in particular as dermatological compositions in conjunction or in admixture with one or more suitable cosmetic and/or pharmaceutical excipients or carriers. The method has an interest particularly in the synthesis of active compounds useful in the fields of cosmetology and/or pharmacology and specifically of dermatology.

Abstract: The invention concerns the production of acrylic acid from propane in the presence of molecular oxygen. Said method consists in passing a gas mixture comprising propane, molecular oxygen, water vapour and, optionally, an inert gas, on a catalyst of formula (I) MolVaTebNbcSidOx to oxidize propane into acrylic acid, the propane/molecular oxygen mol ratio in the initial gas mixture being not less than 0.5.

Abstract: A catalyst composition having the formula: Mo1VaSbbNbcMdOx wherein M is gallium, bismuth, silver or gold, a is 0.01 to 1, b is 0.01 to 1, c is 0.01 to 1, d is 0.01 to 1 and x is determined by the valence requirements of the other components. Other metals, such as tantalum, titanium, aluminum, zirconium, chromium, manganese, iron, ruthenium, cobalt, rhodium, nickel, platinum, boron, arsenic, lithium, sodium, potassium, rubidium, calcium, beryllium, magnesium, cerium, strontium, hafnium, phosphorus, europium, gadolinium, dysprosium, holmium, erbium, thulium, terbium, ytterbium, lutetium, lanthanum, scandium, palladium, praseodymium, neodymium, yttrium, thorium, tungsten, cesium, zinc, tin, germanium, silicon, lead, barium or thallium may also be components of the catalyst. This catalyst is prepared by co-precipitation of metal compounds which are calcined to form a mixed metal oxide catalyst that can be used for the selective conversion of an alkane to an unsaturated carboxylic acid in a one-step process.

Abstract: Compositions including a conjugate of ?-difluoromethylornithine can be applied topically to reduce hair growth.

Abstract: A method of contact catalytic reaction by introducing a gas and a liquid into a lower part of a reaction zone comprising a liquid phase and a catalyst-packed bed held therein, where the catalyst-packed bed is a fixed bed.

Abstract: A method for producing acrylic acid, comprising (a) a absorption step of absorbing acrylic acid-containing gas obtained by oxidizing raw material gas in gas phase as crude acrylic acid-containing solution, (b1) a step of separating high boiling point components that separates the crude high boiling point components at a distillation column as (b) a step of purifying the acrylic acid-containing solution, and further, (c) a decomposition step of decomposing Michael adducts contained in the high boiling point components to prepare acrylic acid and (d) a collection step of collecting acrylic acid generated in the decomposition step (c), whereby the proportion of the amount of maleic acid to a sum of the sum of the maleic acid and maleic anhydride in the high boiling point components that are fed from the high boiling point component separation step (b1) to the decomposition step (c) satisfies a equation below: [ Equation ? ? 1 ] ? ` [ Maleic ? ? acid ? ? ( mass ) ] [

Abstract: Novel thyroid receptor ligands are provided having the general formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12 and R13 are as defined herein. In addition, a method is provided for preventing, inhibiting or treating diseases or disorders associated with metabolic dysfunction or which are dependent upon the expression of a T3 regulated gene, wherein a compound as described above is administered in a therapeutically effective amount.

Abstract: Prodrugs of levodopa, methods of making prodrugs of levodopa, methods of using prodrugs of levodopa, and compositions of prodrugs of levodopa are disclosed.

Abstract: A method of preparation of a highly pure salt of R,R-formoterol L-tartrate is disclosed. The process provides the most thermodynamically stable polymorph by recrystallization of a novel polymorph.

Abstract: Novel polycyclic cannabinoid analogs are presented which have preferentially high affinities for the cannabinoid CB2 receptor sites. The improved receptor affinity makes these analogs therapeutically useful as medications in individuals and animals for treatment of pain, glaucoma, epilepsy, nausea associated with chemotherapy.

Abstract: Describes an integrated process for preparing 1,2-dichloroethylenes. In the described process organic feed material, e.g., C2-C4 aliphatic hydrocarbons and/or chlorinated derivatives of such aliphatic hydrocarbons, is introduced into a first reaction zone 10, e.g., a chlorination zone such as an oxychlorination zone, or a thermal cracking zone; first product effluent from the first reaction zone is forwarded to a second reaction zone 9; trichloroethane is introduced into the second reaction zone and into heat exchange contact with the first product effluent from the first reaction zone, which has a heat content sufficient to cause thermal dehydrochlorination of trichloroethane in the second reaction zone; and second product effluent is removed from the second reaction zone. 1,2-dichloroethylene is recovered by conventional distillation recovery methods from the second product effluent.

Abstract: The invention relates to novel diazoketone derivatives. The invention also relates to processes for homologation of these diazoketone derivatives. The processes are useful for preparing compounds that are caspase inhibitors.

Abstract: A method for producing acrylic acid by absorbing acrylic acid at a high ratio and obtaining an acrylic acid-containing solution of high concentration is provided. This method comprises a step of circulating part of a discharged gas from an absorption step of acrylic acid to the reactor and discarding the remainder to the out side of system while the gas is cooled before circulation to the reactor. By the method, the acrylic acid-containing solution of high concentration is obtained due to decrease of an acrylic acid loss.

Abstract: A method of solvating metal ions in an aromatic organic liquid. The method includes adding an ammonium salt having an organic acid reagent to the aromatic organic liquid. The organic acid reagent comprises a carboxylate having eight (8) or less carbon atoms. Thereafter, an aqueous solution comprising a metal salt is added to the aromatic organic liquid comprising the ammonium salt and the organic acid reagent. As a result, at least 10% by weight of metal ions is solvated in the aromatic organic liquid.

Abstract: A method for the production of acrylic acid comprises (i) a step for introducing a polymerization inhibitor to a stage other than a stage for supplying a raw material and a stage for supplying a reflux of said distilling column or (ii) a step for supplying the acrylic acid recovered by thermally decomposing said oligomer to said stage for dehydration. Thus, the present invention enjoys effective utilization of acrylic acid and exalts the efficiency of production.

Abstract: The invention concerns a method for producing acrylic acid from propane, which consists in passing a gas mixture including propane, water, vapor, and optionally an inert gas and/or molecular oxygen, on a catalyst of formula (I): Mo1VaSbbNbcSidOx, wherein: a ranges between 0.006 and 1, inclusively; b ranges between 0.006 and 1, inclusively; c ranges between 0.006 and 1, inclusively; d ranges between 0 and 3.5, inclusively; and x is the amount of oxygen bound to the other elements and depends on their state of oxidation, for oxidizing propane into acrylic acid, and which is carried out in the presence of molecular oxygen, the propane/molecular oxygen mol ratio in the initial gas mixture is not less than 0.5.